fashion -WSS

fashion

author：explore 2025-08-20 09:41:32 - browse：52685

Amylyx founders — Justin Klee, left, and Joshua Cohen, both co-founders and co-CEO's of Amylyx Pharmaceuticals. Kayana Szymczak for STAT

The Food and Drug Administration has reversed an internal decision and will now review an experimental treatment for amyotrophic lateral sclerosis — a victory for ALS patients and advocates who have been pressuring regulators to act with more urgency against the fatal, neurodegenerative disease.

Amylyx Pharmaceuticals, a Cambridge, Mass.-based drug maker, said Wednesday that it will submit an application for its ALS treatment, called AMX0035, “in the coming months.”

The filing will be based largely on a single clinical trial of AMX0035 completed one year ago that showed a significant slowing of disease progression in patients with ALS. It’s the same study that FDA officials told Amylyx last April was encouraging, but not convincing enough to review for approval on its own. The company was told by FDA staff to conduct another study, gather more positive data, and then file for approval.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Cholera vaccine supplies dangerously low, outbreaks surging

explore

WSS

A year after a Russian missile took her leg, a young Ukrainian gymnast's spirit endures

Using force crossed my mind when examining a defiant young patient

Pfizer is about to make a big push in cancer. Will investors listen?

Travel bans should be based on evidence, not politics or fear

FTX founder Sam Bankman

Laying a path for careers in science

leisure time

fashion

entertainment

Hepatitis C has a cure — but many Americans still lack access to it

Wegovy cuts risk of cardiovascular events by 20%, study finds

In Memoriam: Notable people who died in 2023

Judge schedules Friday hearing on proposed protective order in Jan. 6 case

Heart attack and stroke risk calculators need revising

An Ebola outbreak presents a new mystery involving children

State Dept. review finds Biden bears some blame for Afghanistan failures

5 ways to address the shortage of health care workers

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

CDC advisory group OKs chikungunya vaccine

explore

NEJM study measures Covid brain fog, impact on IQ

Mifepristone protocols being wielded by pill's opponents in Supreme Court case

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

Medicare Advantage isn’t working — for anyone

Doctor of U.S. President Joe Biden says he is fit for duty

Pfizer is about to make a big push in cancer. Will investors listen?

Wikipedia

Wikipedia

explore

entertainment